Regarding the mechanisms used by iNKT cells to eliminate tumor cells in these contexts, it has been shown that the granzyme/perforin pathway is necessary to kill cancer cells in myelomonocytic leukemia [36,101], and T-cell lymphoma [100], whereas TRAIL expression drives apoptosis in AML cells [103]. Here, PRF1 is linked to neoplasm.